GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » FCF Yield %

HLB Science (XKRX:343090) FCF Yield % : -6.33 (As of May. 14, 2024)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, HLB Science's Trailing 12-Month Free Cash Flow is ₩-3,054.02 Mil, and Market Cap is ₩48,229.63 Mil. Therefore, HLB Science's FCF Yield % for today is -6.33%.

The historical rank and industry rank for HLB Science's FCF Yield % or its related term are showing as below:

XKRX:343090' s FCF Yield % Range Over the Past 10 Years
Min: -7.64   Med: 0   Max: 0
Current: -6.33


XKRX:343090's FCF Yield % is ranked better than
65.77% of 1554 companies
in the Biotechnology industry
Industry Median: -14.38 vs XKRX:343090: -6.33

HLB Science's FCF Margin % for the quarter that ended in . 20 was 0.00%.


HLB Science FCF Yield % Historical Data

The historical data trend for HLB Science's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science FCF Yield % Chart

HLB Science Annual Data
Trend Dec22 Dec23
FCF Yield %
-9.40 -7.31

HLB Science Quarterly Data
FCF Yield %

Competitive Comparison of HLB Science's FCF Yield %

For the Biotechnology subindustry, HLB Science's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Science's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Science's FCF Yield % distribution charts can be found below:

* The bar in red indicates where HLB Science's FCF Yield % falls into.



HLB Science FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

HLB Science's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-3054.024 / 41782.784
=-7.31%

HLB Science's annualized FCF Yield % for the quarter that ended in . 20 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
= * 4 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HLB Science FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


HLB Science FCF Yield % Related Terms

Thank you for viewing the detailed overview of HLB Science's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Science (XKRX:343090) Business Description

Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines